Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind placebo-controlled trial of mirtazapine in fibromyalgia
jRCT2080221141Phase 2
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Mirtazapine (Org 3770) with Placebo (2 arms).
02
Drugs
mirtazapine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on jRCT2080221141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221141.